Recent Articles from GlobeNewswire
BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase II/III clinical trial of novel TYK2 inhibitor soficitinib (ICP-332) for the treatment of chronic spontaneous urticaria (CSU).
By InnoCare Pharma · Via GlobeNewswire · February 12, 2026
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced the pricing of an underwritten public offering of 28,600,000 shares of the Company’s common stock (the “Offering”). The shares of common stock are being sold at a public offering price of $1.75 per share, before underwriting discounts and commissions. All of the shares in the Offering are being sold by the Company. The gross proceeds to Coherus from the Offering are expected to be approximately $50.1 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 4,290,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. The Offering is expected to close on or about February 17, 2026, subject to the satisfaction of customary closing conditions.
By Coherus Oncology, Inc. · Via GlobeNewswire · February 12, 2026
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- URBANICA, a direct to consumer premium ergonomic office furniture brand, today announced the expansion of its workstation panel lineup to help teams build focus zones inside open plan offices without permanent construction. The new and expanded panel options are designed to reduce visual distractions, support calmer collaboration and create clearer boundaries in shared work areas, all while keeping layouts flexible for hybrid schedules and changing team sizes.
By URBANICA · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today provided an update on progress at its Redwing Mine in Zimbabwe, confirming that dewatering activities commenced on January 29, 2026, in line with the work plan outlined in the Company’s November 2025 business update. The dewatering phase will enable access to the mine for feasibility studies, including underground condition assessments and detailed engineering evaluations, which will inform the next stages of the restart project at Redwing.
By Namib Minerals · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced it will be added to the MSCI USA Index, effective after close of trading on February 27, 2026.
By IREN · Via GlobeNewswire · February 12, 2026
Atlanta, GA, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flock Safety, the leading safety technology platform dedicated to creating thriving communities, today announced it is pausing further exploration of a potential partnership with Ring.
By Flock Safety · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Solana ETF (TSOL) for staking rewards earned from its SOL holdings.
By 21Shares · Via GlobeNewswire · February 12, 2026
GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN® Nasal Spray. This approval expands the NARCAN® Nasal Spray product suite to include 6-count and 24-count multipack options, specifically designed to meet the needs of partners distributing higher volumes of naloxone. These new formats offer enhanced flexibility with the same trusted product, benefiting community programs and organizations operating large-scale, multi-site, or high-volume distribution programs.
By Emergent BioSolutions · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Plug Power, Inc. (“Plug Power” or the “Company”) (NASDAQ:PLUG) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · February 12, 2026
NEWARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (the “Company”) (NASDAQ: CNXC), a global technology and services leader, today announced that it has priced a public offering of $600 million aggregate principal amount of 6.500% Senior Notes due 2029 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with other available funds, as necessary, to redeem or otherwise repay at or prior to maturity all or a portion of its 6.650% Senior Notes due August 2, 2026 (the “2026 Notes”), of which $800 million aggregate principal amount is outstanding as of the date hereof, and pay related fees and expenses. The Offering is expected to close on February 24, 2026, subject to customary closing conditions.
By Concentrix Solutions Corporation · Via GlobeNewswire · February 12, 2026
OTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The following matter was voted upon at the Annual Meeting of Shareholders of Calian® Group Ltd. (TSX:CGY), held on February 12, 2026, in Ottawa, Ontario. This and other matters voted upon are described in greater detail in the Notice of Annual Meeting of Shareholders and Management Proxy Circular dated December 15, 2025.
By Calian Group Ltd. · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bath & Body Works, Inc. (NYSE:BBWI) and BellRing Brands, Inc. (NYSE:BRBR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2026
Austin, TX, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Spartacus Acquisition Corp. II (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, at $10.00 per unit, including 3,000,000 units pursuant to the full exercise of the overallotment option by the underwriters. The units began trading on the Nasdaq Capital Market (“Nasdaq”) on Wednesday, February 11, 2026 under the ticker symbol “TMTSU.” Each unit consists of one share of the Company’s Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, shares of the Class A ordinary share and warrants are expected to be listed on Nasdaq under the symbols “TMTS” and “TMTSW,” respectively.
By Spartacus Acquisition Corp. II · Via GlobeNewswire · February 12, 2026
Dreamland Baby Co. v. Consumer Product Safety Commission, et al.
By New Civil Liberties Alliance · Via GlobeNewswire · February 12, 2026
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before the open of trading on Friday, February 27, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.
By Treace Medical Concepts, Inc. · Via GlobeNewswire · February 12, 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Smart Digital (SDM) To Contact Him Directly To Discuss Their Options.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2026
DENVER, Feb. 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, will report its fourth quarter 2025 financial results after the U.S. financial markets close on Thursday, March 12, 2026.
By EverCommerce Inc. · Via GlobeNewswire · February 12, 2026
Adjusted EBITDA loss of $29 million and Net Loss of $105 million
By Interfor Corporation · Via GlobeNewswire · February 12, 2026
CLEVELAND, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at Citi’s 2026 Global Industrial Tech and Mobility Conference in Miami, Florida on February 19, 2026 at 11:20 a.m. Eastern time. A live webcast of the presentation will be accessible on Parker's investor information website at investors.parker.com and will be archived on the site.
By Parker-Hannifin Corporation · Via GlobeNewswire · February 12, 2026
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
By mdxhealth · Via GlobeNewswire · February 12, 2026
By Columbus Circle Capital Corp II · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) between August 7, 2024 and February 9, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · February 12, 2026
New York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- D. Boral Acquisition I Corp. (the “Company”) today announced the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at a price of $10.00 per unit for total gross proceeds of $287,500,000. The units began trading on The Nasdaq Global Market under the ticker symbol “DBCAU” on February 11, 2026. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable public warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be traded on The Nasdaq Global Market under the symbols “DBCA” and “DBCAW,” respectively. The Company intends to use the net proceeds from the offering and the simultaneous private placement of units to pursue and consummate a business combination with one or more businesses.
By D. Boral Acquisition I Corp. · Via GlobeNewswire · February 12, 2026
ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026.
By Supernus Pharmaceuticals, Inc. · Via GlobeNewswire · February 12, 2026
This press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on February 27, 2026, the expected expiration date of the Rights Offering.
By AIM ImmunoTech Inc. · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
MUNICH, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Energy, innovation, and European momentum took center stage as more than 800 MONAT Market Partners from across Germany, Austria, and surrounding markets gathered at the ultra-modern BMW Welt & Museum for MONAT Unleashed Germany. The brand’s first major event since expanding into Germany eight months ago made a powerful statement of growth, innovation, and renewed connection.
By Monat Global · Via GlobeNewswire · February 12, 2026
Legendary doughnut shop celebrates its Miami debut with free doughnuts, opening-day giveaways, and a partnership supporting NAMI Miami-Dade.
By Voodoo Doughnut · Via GlobeNewswire · February 12, 2026
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product
By Profusa, Inc. · Via GlobeNewswire · February 12, 2026
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- GB Capital Ltd. (“GB Capital”), a strategic finance, advisory and management firm, today announced that it served as co-advisor to PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC”) in connection with PMGC’s acquisition of SVM Machining, Inc. (“SVM”), a Northern California–based ISO 9001:2015 certified CNC precision machining company.
By GB Capital Ltd. · Via GlobeNewswire · February 12, 2026
New appointments and expanded roles position company for sustained performance
By Advantage Sales & Marketing, LLC dba Advantage Solutions · Via GlobeNewswire · February 12, 2026
LONG BEACH, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its next launch is a dedicated mission on its HASTE rocket for the Department of War’s Defense Innovation Unit (DIU).
By Rocket Lab Corporation · Via GlobeNewswire · February 12, 2026
NEW YORK -- Wix.com Ltd. (Nasdaq: WIX), today announced that it will report its results for the fourth quarter and full year ended December 31, 2025 before the market opens on Wednesday, March 4, 2026. Management will host a conference call and webcast that morning at 8:30 a.m. ET to answer questions about the Company's financial results. Prior to the conference call and webcast, Wix will issue a press release reporting these results along with a shareholder update and additional materials at https://investors.wix.com/.
By Wix.com, Ltd. · Via GlobeNewswire · February 12, 2026
Brokers Reminded of Tomorrow’s Deadline
By Trump Media & Technology Group · Via GlobeNewswire · February 12, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will announce its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026.
By Profound Medical Corp. · Via GlobeNewswire · February 12, 2026
HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced it has been awarded a multi-year Integrated Completions contract by TotalEnergies in Denmark. The contract underscores TotalEnergies’ confidence in Weatherford’s technical expertise, execution capabilities, and commitment to delivering innovative, high-quality well solutions.
By Weatherford International, LLC · Via GlobeNewswire · February 12, 2026
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
By Globus Medical · Via GlobeNewswire · February 12, 2026
COLUMBUS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its participation in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference, taking place March 1-3, 2026, in Naples, Florida.
By Root, Inc. · Via GlobeNewswire · February 12, 2026
CALGARY, Alberta, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) will release its fourth-quarter and full-year 2025 results on Thursday, February 19, 2026. The news release will provide consolidated fourth-quarter and full-year operating and financial information. The company’s financial statements will be available on Cenovus’s website, cenovus.com.
By Cenovus Energy Inc. · Via GlobeNewswire · February 12, 2026
RIDGELAND, Miss., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced with deep sadness the passing of Jim Poole, a valued member of its Board of Directors.
By Cal-Maine Foods, Inc. · Via GlobeNewswire · February 12, 2026
Selected Highlights
By Mercer International Inc. · Via GlobeNewswire · February 12, 2026
MOUNT LAUREL, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) announced today that its Board of Directors has declared a quarterly cash dividend of $0.80 per share of its common stock payable on April 7, 2026, to shareholders of record as of the close of business on March 17, 2026.
By J & J Snack Foods Corp. · Via GlobeNewswire · February 12, 2026
Nicholas Fink to Succeed Bill Newlands as President and Chief Executive Officer Effective April 13, 2026, Newlands to Serve as Strategic Advisor to Help Ensure a Smooth Leadership Transition
By Constellation Brands, Inc. · Via GlobeNewswire · February 12, 2026
CALHOUN, Ga., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced fourth quarter 2025 net earnings of $42 million and earnings per share (“EPS”) of $0.68; adjusted net earnings were $124 million, and adjusted EPS was $2.00. Net sales for the fourth quarter of 2025 were $2.7 billion, up 2.4% as reported and down 3.3% on an adjusted basis versus the prior year. During the fourth quarter of 2024, the Company reported net sales of $2.6 billion, net earnings of $90 million and earnings per share of $1.43; adjusted net earnings were $123 million, and adjusted EPS was $1.95.
By Mohawk Industries, Inc. · Via GlobeNewswire · February 12, 2026
HAMILTON, Bermuda, Feb. 12, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced that International Medical Group (“IMG”), a leader in global insurance benefits and assistance services, and SiriusPoint’s wholly owned subsidiary, will acquire World Nomads, a division of Australian health insurer, nib Group.
By SiriusPoint Ltd. · Via GlobeNewswire · February 12, 2026
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced that Bill Adams will retire as Chief Financial Officer, effective March 15th, 2026. The Company has engaged a leading executive search firm to identify a successor, and Mr. Adams will continue in an advisory capacity following his retirement date to support the transition.
By NervGen Pharma Corp. · Via GlobeNewswire · February 12, 2026
SAN JOSE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- H2O America (NASDAQ: HTO) expects to report its financial results for the fourth quarter and full-year 2025 and provide forward-looking guidance after the close of the market on Wednesday, February 25, 2026.
By H2O America · Via GlobeNewswire · February 12, 2026
Reported Positive Net Income Set Records for Revenue and Adjusted EBITDA
By DK Crown Holdings Inc. · Via GlobeNewswire · February 12, 2026
SANTA MONICA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of The Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on March 30, 2026, to stockholders of record at the close of business on March 16, 2026.
By Macerich Company · Via GlobeNewswire · February 12, 2026
Fan-Favorite Fish Taco Returns Alongside New Premium Big Fish Sandwich
By Taco John's · Via GlobeNewswire · February 12, 2026
ORLANDO, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, will host a conference call on Thursday, February 26, 2026 to provide an update on recent corporate developments. A press release discussing such developments and other activity from the fourth quarter and fiscal year ending December 31, 2025, will be provided prior to the conference call.
By PureCycle Technologies · Via GlobeNewswire · February 12, 2026
Enters into Cooperation Agreement with Anson Funds
By SPS Commerce, Inc. · Via GlobeNewswire · February 12, 2026
SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced the closing of its initial public offering of 23,575,000 shares of its Class A common stock, which includes the exercise in full by the underwriters of their option to purchase 3,075,000 additional shares, at the initial public offering price of $25.00 per share, less underwriting discounts and commissions. All of the shares were offered by the Company.
By SOLV Energy, Inc. · Via GlobeNewswire · February 12, 2026
New York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CCS Fundraising today announced the release of its fifth annual Philanthropy Pulse report, drawing on survey responses from more than 600 nonprofit organizations to examine how fundraising leaders are navigating a rapidly shifting philanthropic landscape and where they are focusing strategy for the year ahead.The 2026 CCS Philanthropy Pulse offers a snapshot of how nonprofit leaders are responding to increased complexity across revenue, staffing, policy, and technology, and how they are approaching the year ahead.Taken together, the findings suggest a sector that is adapting—not retreating—as leaders prioritize sustainability, structure, and thoughtful use of resources. “Nonprofit leaders are working in a dynamic moment of real change, and what stands out is their determination to adapt,” said Lindsay Marciniak, Managing Partner at CCS Fundraising. “This year’s Philanthropy Pulse highlights an industry that is actively refining strategy, utilizing new technology, and finding new ways to engage donors in meaningful, effective ways.”The report analyzes trends across organizational size and mission focus, offering insight into how nonprofits are responding to changing donor behavior, financial considerations, and operational needs.Key takeaways from the 2026 CCS Philanthropy Pulse reflect how nonprofit leaders are navigating growth and complexity across multiple dimensions:
By CCS Fundraising · Via GlobeNewswire · February 12, 2026
Company delivers 100th consecutive quarter of topline growth
By SPS Commerce, Inc. · Via GlobeNewswire · February 12, 2026
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced a proposed underwritten public offering of its common stock (the “Offering”). In addition, Coherus intends to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the Offering are being offered by Coherus.
By Coherus Oncology, Inc. · Via GlobeNewswire · February 12, 2026
CINCINNATI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or “the Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that the Company’s Board of Directors declared monthly dividend distributions of $0.1083 per share of the Company’s common stock payable on April 1, 2026; May 1, 2026; and June 2, 2026 to stockholders of record as of March 16, 2026; April 15, 2026; and May 15, 2026, respectively.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · February 12, 2026
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · February 12, 2026
VISTA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the 2026 fiscal second quarter ended December 31, 2025.
By Flux Power · Via GlobeNewswire · February 12, 2026
Shelton, CT, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced that Gerben Bakker, Chairman and Chief Executive Officer, and Joe Capozzoli, Chief Financial Officer, will appear at the Barclays Industrial Select Conference. The event will be webcast and is scheduled to begin at 8:40AM ET on Thursday, February 19, 2026.
By Hubbell Inc. · Via GlobeNewswire · February 12, 2026
Roadzen delivers 18.8% revenue increase and reduces operating loss by 25.4% over prior-year quarter
By Roadzen Inc. · Via GlobeNewswire · February 12, 2026
JERSEY CITY, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in AI data protection, unifying data security, governance, and resilience, today announced that members of the Company’s executive management team will present at the following investor conferences:
By AvePoint, Inc. · Via GlobeNewswire · February 12, 2026
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company’s fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com.
By Amwell · Via GlobeNewswire · February 12, 2026
SAXONBURG, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, proudly announced that six of its products have received awards in the 2026 Lightwave Innovation Reviews, matching the Company’s achievement in 2025 and underscoring Coherent’s continued leadership in optical networking innovation.
By Coherent Corp. · Via GlobeNewswire · February 12, 2026
BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences:
By Caribou Biosciences, Inc. · Via GlobeNewswire · February 12, 2026
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today reported financial results and provided a business update for the three months ended December 31, 2025.
By Rezolute, Inc. · Via GlobeNewswire · February 12, 2026
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in the upcoming months.
By TheRas, Inc. (d/b/a BBOT) · Via GlobeNewswire · February 12, 2026
Stuart, Florida, Feb. 12, 2026 (GLOBE NEWSWIRE) -- MILFAM LLC (“MILFAM”), on behalf of the Board of Directors (the “Board”) of Scully Royalty Ltd. (NYSE:SRL) (“Scully”), announced that on February 11, 2026, Tacora Resources Inc. (“Tacora”) commenced an interpleader action in the Ontario Superior Court of Justice (“Court”), naming as respondents Scully, 1128349 B.C. Ltd. (“112”), MILFAM and the individual members of the Board to pay the January 2026 royalty payment into the Court. The application was commenced after the former Scully board of directors and management demanded payment from Tacora of a royalty owing under a mining lease to which 112 and Tacora are parties. The Board believes that the demand was made by individuals who lacked lawful authority to do so. The Board had previously sought to safeguard the payment.
By Milfam LLC · Via GlobeNewswire · February 12, 2026
NAPERVILLE, Ill., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science-backed longevity, hormone optimization, and medical aesthetics, announced the opening of its newest location in Naperville, Illinois. Officially opening January 22, 2026, the Naperville center represents the brand’s first Illinois location and marks a major milestone in its continued national expansion.
By Serotonin · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2025 financial results before the opening of the market on Thursday, February 26, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
By Anika Therapeutics Inc. · Via GlobeNewswire · February 12, 2026
BOSTON HEIGHTS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, announced that Michael Rengel has been appointed Chief Merchandising Officer, effective February 23, 2026.
By Arhaus, Inc. · Via GlobeNewswire · February 12, 2026